AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15782753 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral to a cessation program
Number of subjects: 1941
Study 15782753 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription for nicotine patches
Number of subjects: 1941
Study 15782753 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to quit smoking
Number of subjects: 1941
Study 15782753 — intervention group
Group type: EXPERIMENTAL
Intervention: Quit attempts in the prior year
Number of subjects: 1941
Study 12056714 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiotaping of follow-up consultations
Number of subjects: 52
Study 12056714 — intervention group
Group type: COMPARATOR
Intervention: Control group (no audiotaping)
Number of subjects: 52
Study 10616628 — intervention group
Group type: COMPARATOR
Intervention: Family support alone
Number of subjects: 0
Study 10616628 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic psychosocial interventions based on an assessment of need
Number of subjects: 0
Study 7577208 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin plus etoposide (standard chemotherapy)
Number of subjects: 0
Study 7577208 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus paclitaxel
Number of subjects: 0
Study 7680493 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine myelin
Number of subjects: 30
Study 7680493 — intervention group
Group type: COMPARATOR
Intervention: Control protein
Number of subjects: 30
Study 3083100 — intervention group
Group type: EXPERIMENTAL
Intervention: Unloaded pedalling (0 W), 50 W, 100 W, 150 W
Number of subjects: 9
Study 3083100 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation at rate 24/min and normal tidal volume
Number of subjects: 9
Study 3083100 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation at normal rate and tidal volume of 1.5 l
Number of subjects: 9
Study 3083100 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation at rate 24/min and tidal volume of 1.5 l
Number of subjects: 9
Study 3083100 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation at rate 24/min and tidal volume of 1.4 l
Number of subjects: 9
Study 30251010 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ10 supplementation (120 mg/day)
Number of subjects: 60
Study 30251010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 28081351 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 15 mg/kg
Number of subjects: 0
Study 28081351 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 5 mg/kg
Number of subjects: 0
Study 28081351 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 25053420 — intervention group
Group type: EXPERIMENTAL
Intervention: Stopping breastfeeding before 6 months
Number of subjects: 964
Study 25053420 — intervention group
Group type: EXPERIMENTAL
Intervention: Low birthweight
Number of subjects: 964
Study 25053420 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal completion of high school education
Number of subjects: 964
Study 22162533 — intervention group
Group type: EXPERIMENTAL
Intervention: Istradefylline (20 to 40 mg/d)
Number of subjects: 1760
Study 22162533 — intervention group
Group type: EXPERIMENTAL
Intervention: Istradefylline (40 mg/d)
Number of subjects: 1760
Study 22162533 — intervention group
Group type: EXPERIMENTAL
Intervention: Istradefylline (dose increase)
Number of subjects: 1760
Study 20093065 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade III postero-anterior rotatory joint mobilisation technique applied to T4 at a frequency of 0.5 Hz
Number of subjects: 36
Study 20093065 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 36
Study 18555813 — intervention group
Group type: EXPERIMENTAL
Intervention: Drospirenone 3 mg / Ethinylestradiol 20 mcg in a 24/4 regimen
Number of subjects: 104
Study 18555813 — intervention group
Group type: COMPARATOR
Intervention: Conventional 21/7 regimen
Number of subjects: 104
Study 15756154 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural administration of naropina 0.2%+fentanyl 4 microg/mL by elastomeric pump (rate 5 ml/h)
Number of subjects: 50
Study 15756154 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion of tramadol 600 mg+ketorolac trometamina 120 mg+ranitidina 200 mg+ondansetron 16 mg by elastomeric pump (rate 5 ml/h for 48 hours)
Number of subjects: 50
Study 12427649 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin
Number of subjects: 43
Study 12427649 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin plus 600 mg/d vitamin E
Number of subjects: 43
Study 10320598 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol elixir (40 mg x kg(‐1)) 90 min before surgery
Number of subjects: 81
Study 10320598 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol suppositories (40 mg x kg(‐1)) intraoperatively
Number of subjects: 81
Study 7588352 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (3 mg/kg/daily per os)
Number of subjects: 60
Study 7588352 — intervention group
Group type: EXPERIMENTAL
Intervention: Flucytosine (100 mg/kg/daily per os)
Number of subjects: 60
Study 7588352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 1790034 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal interactional intervention
Number of subjects: 202
Study 1790034 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal interactional intervention
Number of subjects: 202
Study 1790034 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions combined
Number of subjects: 202
Study 6794145 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluproquazone
Number of subjects: 48
Study 6794145 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 48
Study 6794145 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 48
Study 30957170 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks of grazoprevir/elbasvir therapy
Number of subjects: 82
Study 30957170 — intervention group
Group type: COMPARATOR
Intervention: 12 weeks of grazoprevir/elbasvir therapy
Number of subjects: 82
Study 30957170 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks of grazoprevir/elbasvir therapy with high HCV-1b load (≥1,500,000 IU/mL)
Number of subjects: 82
Study 30957170 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks of grazoprevir/elbasvir therapy with baseline Y93H RAS frequency >15%
Number of subjects: 82
Study 30957170 — intervention group
Group type: COMPARATOR
Intervention: 12 weeks of grazoprevir/elbasvir therapy with high HCV-1b load and baseline Y93H RAS frequency >15%
Number of subjects: 82
Study 26596997 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Meal Intervention (FMI)
Number of subjects: 23
Study 26596997 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Therapy with Family Meal Intervention (FTFM)
Number of subjects: 23
Study 26596997 — intervention group
Group type: COMPARATOR
Intervention: Family Therapy without Family Meal Intervention (FT)
Number of subjects: 23
Study 25722378 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (S; n = 24)
Number of subjects: 96
Study 25722378 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (E; n = 26)
Number of subjects: 96
Study 25722378 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined strength + endurance training (SE; n = 24)
Number of subjects: 96
Study 25722378 — intervention group
Group type: COMPARATOR
Intervention: Physical activity recommendations (C; n = 22)
Number of subjects: 96
Study 23420115 — intervention group
Group type: EXPERIMENTAL
Intervention: Theobromine 250 mg
Number of subjects: 80
Study 23420115 — intervention group
Group type: EXPERIMENTAL
Intervention: Theobromine 500 mg
Number of subjects: 80
Study 23420115 — intervention group
Group type: EXPERIMENTAL
Intervention: Theobromine 1000 mg
Number of subjects: 80
Study 23420115 — intervention group
Group type: COMPARATOR
Intervention: Caffeine 200 mg
Number of subjects: 80
Study 21536693 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch to monotherapy
Number of subjects: 127
Study 21536693 — intervention group
Group type: COMPARATOR
Intervention: Stay on polypharmacy
Number of subjects: 127
Study 19401662 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased systolic blood pressure (from 105 ± 10 to 135 ± 14 mmHg)
Number of subjects: 16
Study 19401662 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased tidal volume (from 6 to 10 ml kg(‐1))
Number of subjects: 16
Study 19401662 — intervention group
Group type: COMPARATOR
Intervention: Baseline measurements
Number of subjects: 16
Study 16963248 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose purified soy isoflavones (genistein, 558 mg/day; daidzein, 296 mg/day; glycitein, 44 mg/day) for 84 days
Number of subjects: 30
Study 16963248 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose purified soy isoflavones
Number of subjects: 30
Study 15783119 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid (INH) 300 mg with pyridoxine 20 mg daily for 1 year or until TB development
Number of subjects: 90
Study 15783119 — intervention group
Group type: COMPARATOR
Intervention: Control group (no INH prophylaxis)
Number of subjects: 90
Study 11522468 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 0
Study 11522468 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9926498 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive activity-based program implemented in local elementary schools
Number of subjects: 0
Study 9926498 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 7873469 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting nitrates
Number of subjects: 0
Study 7873469 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers or calcium antagonists (used in association with nitrates)
Number of subjects: 0
Study 7873469 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 3348157 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin-mineral supplement providing 0.5 mg/d vitamin B-6
Number of subjects: 23
Study 3348157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 3348157 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (supplemented and placebo)
Number of subjects: 23
Study 31550352 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (ASI) 50 units
Number of subjects: 184
Study 30871936 — intervention group
Group type: EXPERIMENTAL
Intervention: Wondaleaf‐Cap® (WLC)
Number of subjects: 50
Study 30871936 — intervention group
Group type: EXPERIMENTAL
Intervention: Wondaleaf‐On‐Man® (WLM)
Number of subjects: 50
Study 30871936 — intervention group
Group type: COMPARATOR
Intervention: Durex®‐Together (DT)
Number of subjects: 50
Study 28442892 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg orodispersible film
Number of subjects: 53
Study 28442892 — intervention group
Group type: COMPARATOR
Intervention: Film-coated 100 mg tablet (Viagra®)
Number of subjects: 53
Study 28442892 — intervention group
Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 53
Study 25487006 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual pressure before benzathine penicillin injection
Number of subjects: 51
Study 25487006 — intervention group
Group type: COMPARATOR
Intervention: Standard injection technique
Number of subjects: 51
Study 23180210 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training (INT)
Number of subjects: 0
Study 23180210 — intervention group
Group type: COMPARATOR
Intervention: Eucaloric steady state aerobic training (AER)
Number of subjects: 0
Study 20887742 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-rich supplements (80±21g protein intake)
Number of subjects: 24
Study 20887742 — intervention group
Group type: COMPARATOR
Intervention: Isoenergetic combination of carbohydrate and fat supplements (59±11g protein intake)
Number of subjects: 24
Study 20887742 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-rich supplements
Number of subjects: 24
Study 20887742 — intervention group
Group type: COMPARATOR
Intervention: Isoenergetic combination of carbohydrate and fat supplements
Number of subjects: 24
Study 19202626 — intervention group
Group type: EXPERIMENTAL
Intervention: Nootropil
Number of subjects: 0
Study 19202626 — intervention group
Group type: COMPARATOR
Intervention: No Nootropil (Control)
Number of subjects: 0
Study 16791663 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat and moisture exchanger
Number of subjects: 9
Study 16791663 — intervention group
Group type: EXPERIMENTAL
Intervention: Active heat and moisture exchanger
Number of subjects: 9
Study 16791663 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated humidifier
Number of subjects: 9
Study 14508205 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg daily)
Number of subjects: 22
Study 14508205 — intervention group
Group type: COMPARATOR
Intervention: Lercanidipine (20 mg daily)
Number of subjects: 22
Study 14508205 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 22
Study 14508205 — intervention group
Group type: COMPARATOR
Intervention: Lercanidipine
Number of subjects: 22
Study 11025232 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 3 microg/kg IV
Number of subjects: 29
Study 11025232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 8619389 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen plus UFT (400 mg/day: group B)
Number of subjects: 34
Study 8619389 — intervention group
Group type: COMPARATOR
Intervention: Estrogen alone (Honvan 200 mg/day or presexol 1 mg/day: group A)
Number of subjects: 34
Study 1443954 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute event data
Number of subjects: 100
Study 1443954 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative risk reductions
Number of subjects: 100
Study 1443954 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial reporting 77 persons treated for 5 years to prevent one myocardial infarction
Number of subjects: 100
Study 4015740 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprofen 200 mg/ml i.m. (3 injections/day for 7 days)
Number of subjects: 45
Study 4015740 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 25 mg/ml i.m. (3 injections/day for 7 days)
Number of subjects: 45
Study 4015740 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 injections/day for 7 days)
Number of subjects: 45
Study 31272477 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotics (APs) alone
Number of subjects: 90
Study 31272477 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological Interventions (PI) alone (Cognitive Behavioural Therapy and Family Intervention)
Number of subjects: 90
Study 31272477 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Antipsychotics and Psychological Interventions
Number of subjects: 90
Study 30058395 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavioral Therapy‐Corrections Modified (DBT‐CM)
Number of subjects: 130
Study 30058395 — intervention group
Group type: COMPARATOR
Intervention: Health Promotion (HP) program
Number of subjects: 130
Study 26863321 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (10 sessions)
Number of subjects: 49
Study 26863321 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga practice frequency after treatment
Number of subjects: 49
Study 26863321 — intervention group
Group type: COMPARATOR
Intervention: Control group (seminar in women's health)
Number of subjects: 49
Study 23389831 — intervention group
Group type: COMPARATOR
Intervention: Helicopter transport
Number of subjects: 330
Study 23389831 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground transport
Number of subjects: 330
Study 23389831 — intervention group
Group type: COMPARATOR
Intervention: Modified Rankin Scale at 3 months
Number of subjects: 330
Study 23389831 — intervention group
Group type: COMPARATOR
Intervention: 30-day mortality
Number of subjects: 330
Study 23389831 — intervention group
Group type: COMPARATOR
Intervention: 1-year mortality
Number of subjects: 330
Study 22157329 — intervention group
Group type: EXPERIMENTAL
Intervention: Acotiamide 100 mg three times a day for 4 weeks
Number of subjects: 0
Study 22157329 — intervention group
Group type: EXPERIMENTAL
Intervention: Acotiamide 100 mg
Number of subjects: 0
Study 22157329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22157329 — intervention group
Group type: EXPERIMENTAL
Intervention: Acotiamide and Placebo
Number of subjects: 0
Study 19825809 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline haemoglobin levels
Number of subjects: 32170
Study 16959907 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute heavy resistance exercise protocol (AHREP; 6 x 10 repetitions parallel squats, 80% 1 repetition maximum)
Number of subjects: 10
Study 16959907 — intervention group
Group type: COMPARATOR
Intervention: Control (Cont; rest)
Number of subjects: 10
Study 16959907 — intervention group
Group type: EXPERIMENTAL
Intervention: AHREP (F(maintainers))
Number of subjects: 10
Study 16959907 — intervention group
Group type: EXPERIMENTAL
Intervention: AHREP (F(reducers))
Number of subjects: 10
Study 15816570 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: 3 mL demand dose with 6 min lockout interval
Number of subjects: 84
Study 15816570 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: 6 mL demand dose with 12 min lockout interval
Number of subjects: 84
Study 15816570 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: 9 mL demand dose with 18 min lockout interval
Number of subjects: 84
Study 12774848 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (400 mL, 279.6 mg total anthocyanins)
Number of subjects: 9
Study 12774848 — intervention group
Group type: COMPARATOR
Intervention: Red grape juice (400 mL, 283.5 mg total anthocyanins)
Number of subjects: 9
Study 12774848 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine anthocyanins
Number of subjects: 9
Study 12774848 — intervention group
Group type: COMPARATOR
Intervention: Red grape juice anthocyanins
Number of subjects: 9
Study 10563230 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic drugs (metoprolol, divalproex, amitriptyline, atenolol, flunarizine, naproxen)
Number of subjects: 0
Study 10563230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8740095 — intervention group
Group type: COMPARATOR
Intervention: 200 mg cefpodoxime proxetil (reference)
Number of subjects: 12
Study 8740095 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg cefpodoxime and 200 mg acetylcysteine (test)
Number of subjects: 12
Study 1923440 — intervention group
Group type: EXPERIMENTAL
Intervention: Listerine Antiseptic (LA) rinse
Number of subjects: 96
Study 1923440 — intervention group
Group type: COMPARATOR
Intervention: Hydroalcoholic control rinse
Number of subjects: 96
Study 6622240 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-usable temporary one-size prosthesis of endoskeletal type with adjustable tube length, training started 2-4 weeks after amputation and lasted for 1-4 weeks.
Number of subjects: 95
Study 31367995 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual information via a video depicting miniscrew application (study group, 44 patients)
Number of subjects: 88
Study 31367995 — intervention group
Group type: COMPARATOR
Intervention: Verbal information about the procedure (control group, 44 patients)
Number of subjects: 88
Study 29864037 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 74
Study 29864037 — intervention group
Group type: COMPARATOR
Intervention: Bupropion
Number of subjects: 74
Study 27044360 — intervention group
Group type: EXPERIMENTAL
Intervention: Health TAPESTRY approach
Number of subjects: 316
Study 27044360 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 316
Study 24147869 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand alverine citrate/simeticone (ACS) treatment
Number of subjects: 436
Study 24147869 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment (mainly antispasmodics)
Number of subjects: 436
Study 22231417 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA (BoNT‐ONA; Botox)
Number of subjects: 53
Study 22231417 — intervention group
Group type: EXPERIMENTAL
Intervention: abobotulinumtoxinA (BoNT‐ABO; Dysport)
Number of subjects: 53
Study 21147706 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (300,000 IU ergocalciferol, 4 times/year)
Number of subjects: 50
Study 21147706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 21147706 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 50
Study 18179286 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 134
Study 18179286 — intervention group
Group type: COMPARATOR
Intervention: Minimal support control condition
Number of subjects: 134
Study 15574551 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (2 x 10(6) KIU loading dose, 2 x 10(6) KIU added to circuit prime, continuous infusion of 5 x 10(5) KIU/hr)
Number of subjects: 36
Study 15574551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 11264758 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranlukast
Number of subjects: 197
Study 11264758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 9832483 — intervention group
Group type: COMPARATOR
Intervention: Control diet (low in fruits, vegetables, and dairy products, 37% of calories from fat)
Number of subjects: 123
Study 9832483 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruits and vegetables diet (rich in fruits and vegetables, otherwise similar to control diet)
Number of subjects: 123
Study 9832483 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination diet (rich in fruits, vegetables, and low-fat dairy products, reduced in fat)
Number of subjects: 123
Study 9832483 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 123
Study 9832483 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruits and vegetables diet
Number of subjects: 123
Study 9832483 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination diet
Number of subjects: 123
Study 8126691 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosure induction (three weekly 20-min individual sessions discussing a stressful topic)
Number of subjects: 76